Morgan Stanley’s Citius Pharmaceuticals CTXR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $95 | Hold |
|
|||||
|
2025
Q1 | $89 | Sell |
|
|||||
|
2024
Q4 | $1.27K | Buy |
|
|||||
|
2024
Q3 | $751 | Sell |
|
|||||
|
2024
Q2 | $5.69K | Sell |
|
|||||
|
2024
Q1 | $172K | Sell |
|
|||||
|
2023
Q4 | $369K | Buy |
|
|||||
|
2023
Q3 | $52K | Sell |
|
|||||
|
2023
Q2 | $125K | Sell |
|
|||||
|
2023
Q1 | $160K | Buy |
|
|||||
|
2022
Q4 | $88K | Sell |
|
|||||
|
2022
Q3 | $179K | Sell |
|
|||||
|
2022
Q2 | $191K | Buy |
|
|||||
|
2022
Q1 | $83K | Buy |
|
|||||
|
2021
Q4 | $61K | Buy |
|
|||||
|
2021
Q3 | $25K | Buy |
|
|||||
|
2021
Q2 | $30K | Sell |
|
|||||
|
2021
Q1 | $71K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $29K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $0 | Buy |
|
|||||
|
2018
Q2 | $0 | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $1K | Buy |
|